IceCure Medical
Medical Equipment ManufacturingHaifa, Israel51-200 Employees
IceCure Medical is a mid-sized medical device company based in the Haifa region of Israel, specializing in cryoablation that uses liquid nitrogen to treat benign and malignant tumors. Its flagship ProSense System rapidly reaches ultra-cold temperatures to freeze and destroy tumor tissue, enabling procedures to be performed in office-based settings without the special safety precautions required for some other cryoablation gases such as argon. The system is cleared for FDA and CE-marked use and has worldwide distribution. The company supports its approach with clinical experience spanning breast, kidney, thoracic surgery, and musculoskeletal lesions. In 2024 it completed the ICE3 Clinical Trial for cryoablation of low-risk, early-stage breast cancer without excision, reporting a high rate of local-control and favorable patient and physician satisfaction, as well as minimal pain and rapid recovery. In 2026 IceCure engaged with the broader medical community through attendance at industry events such as ASBrS 2026 and the SBI Breast Imaging Symposium.
1-888-653-2347 
support@leadiq.com 
